MedTrace Logo

Efficacy and Pharmacokinetics of Meropenem in Severe Septic Patients

NCT03645668 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2020-03-13

No results posted yet for this study

Summary

The experimental and control group were used different administration of Meropenem through monitoring the Meropenem plasma concentration and clinical data

Conditions

Interventions

DRUG

Meropenem Injection

Different administration types between two groups

Sponsors & Collaborators

  • Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

    lead OTHER

Principal Investigators

  • Aihua FEI · Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-30
Primary Completion
2019-11-14
Completion
2019-12-14

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03645668 on ClinicalTrials.gov